跳转至内容
Merck
CN
所有图片(6)

文件

安全信息

ZRB2724

Anti-CD86 Antibody, clone 2H2 ZooMAb® Rabbit Monoclonal

newenhanced validation

recombinant, expressed in HEK 293 cells

登录查看公司和协议定价

别名:
Activation B7-2 antigen, B70, BU63, CD28LG2, CTLA-4 counter-receptor B7.2, FUN-1
UNSPSC代码:
12352203

生物来源

rabbit

质量水平

重组

expressed in HEK 293 cells

偶联物

unconjugated

抗体形式

purified antibody

抗体产品类型

primary antibodies

克隆

2H2, recombinant monoclonal

描述

recombinant, expressed in HEK 293 cells

产品线

ZooMAb® learn more

形式

lyophilized

分子量

calculated mol wt 38 kDa
observed mol wt ~55 kDa

纯化方式

using Protein A

种属反应性

human

种属反应性(根据同源性预测)

monkey

包装

antibody small pack of 25

增强验证

recombinant expression
Learn more about Antibody Enhanced Validation

技术

affinity binding assay: suitable
flow cytometry: suitable
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable

同位素/亚型

IgGκ

表位序列

Extracellular domain

Protein ID登记号

UniProt登记号

运输

ambient

储存温度

2-8°C

基因信息

human ... CD86(942)

一般描述

ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.

特异性

Clone 2H2 is a ZooMAb® rabbit recombinant monoclonal antibody that detects CD86. It targets an epitope within 16 amino acids from the extracellular domain.

免疫原

KLH-conjugated linear peptide corresponding to 16 amino acids from the extracellular domain of human CD86.

应用

Quality Control Testing

Evaluated by Western Blotting with MCF-7.

Western Blotting Analysis: A 1:10,000 dilution of this antibody detected CD86 in MCF-7 cell lysate.

Tested Applications

Western Blotting Analysis: A 1:10,000 dilution from a representative lot detected CD86 in human spleen tissue lysate and a 1:50,000 dilution detected T7/HIS-tagged, human recombinant CD86.

Immunohistochemistry (Paraffin) Analysis: A 1:1,000 dilution from a representative lot detected CD86 in human tonsil tissue sections.

Flow Cytometry Analysis: 1 µg from a representative lot detected CD86 in one million human peripheral blood mononuclear cells (PBMC).

Affinity Binding Assay: A representative lot of this antibody bound CD86 peptide with at least one thousand-fold (1,000X) higher than with non-specific control peptide.

Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected CD86 in HDLM-2 cells.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

目标描述

T-lymphocyte activation antigen CD86 (UniProt: P42081; also known as Activation B7-2 antigen, B70, BU63, CTLA-4 counter-receptor B7.2, FUN-1) is encoded by the CD86 (also known as CD28LG2) gene (Gene ID: 942) in human. CD86 is a type I transmembrane protein belonging to the immunoglobulin superfamily, containing an extracellular Ig-like V-type (aa 33-131) and Ig-like C2-type (aa 15-225) domains essential for T cell interaction, a transmembrane domain (aa 248-268) and a cytoplasmic domain. The extracellular domain of CD86 is responsible for binding to CD28 or CTLA-4 on T cells. CD86 is expressed on the surface of antigen-presenting cells, including dendritic cells, macrophages, and B cells. Its expression is upregulated upon activation of these cells, which typically occurs during an immune response to pathogens. Its dysregulation has been implicated in autoimmune diseases such as rheumatoid arthritis and multiple sclerosis, allergic reactions, and transplant rejection, making it a potential target for immunotherapy. In some cancers, the manipulation of CD86 and its pathways is explored for therapeutic cancer vaccines.

外形

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

重悬

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

储存及稳定性

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

法律信息

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门